First Horizon Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1M | Buy |
162,391
+7,361
| +5% | +$1.37M | 0.78% | 37 |
|
|
2025
Q1 | $32.5M | Sell |
155,030
-23,439
| -13% | -$4.56M | 0.91% | 30 |
|
|
2024
Q4 | $31.7M | Buy |
178,469
+4,344
| +2% | +$799K | 0.89% | 29 |
|
|
2024
Q3 | $34.4M | Buy |
174,125
+2,014
| +1% | +$376K | 0.96% | 26 |
|
|
2024
Q2 | $29.5M | Buy |
172,111
+1,304
| +0.8% | +$216K | 0.9% | 27 |
|
|
2024
Q1 | $31.1M | Sell |
170,807
-1,034
| -0.6% | -$178K | 0.96% | 23 |
|
|
2023
Q4 | $26.6M | Sell |
171,841
-1,256
| -0.7% | -$183K | 0.88% | 25 |
|
|
2023
Q3 | $25.8M | Buy |
173,097
+1,312
| +0.8% | +$193K | 0.93% | 22 |
|
|
2023
Q2 | $23.1M | Buy |
171,785
+811
| +0.5% | +$119K | 0.8% | 31 |
|
|
2023
Q1 | $27.2M | Buy |
170,974
+8,043
| +5% | +$1.23M | 0.97% | 19 |
|
|
2022
Q4 | $26.3M | Sell |
162,931
-1,334
| -0.8% | -$205K | 0.97% | 20 |
|
|
2022
Q3 | $22M | Sell |
164,265
-3,386
| -2% | -$486K | 0.88% | 24 |
|
|
2022
Q2 | $25.7M | Buy |
167,651
+87,643
| +110% | +$13.4M | 0.91% | 22 |
|
|
2022
Q1 | $13M | Sell |
80,008
-105,978
| -57% | -$15.4M | 0.71% | 34 |
|
|
2021
Q4 | $25.2M | Buy |
185,986
+45
| +0% | +$5.32K | 0.76% | 33 |
|
|
2021
Q3 | $20.1M | Buy |
185,941
+36,124
| +24% | +$4.13M | 0.66% | 41 |
|
|
2021
Q2 | $16.9M | Buy |
149,817
+4,047
| +3% | +$456K | 0.91% | 29 |
|
|
2021
Q1 | $15.8M | Buy |
145,770
+9,720
| +7% | +$1.04M | 0.91% | 29 |
|
|
2020
Q4 | $14.6M | Buy |
136,050
+4,475
| +3% | +$430K | 0.98% | 26 |
|
|
2020
Q3 | $11.5M | Buy |
131,575
+3,926
| +3% | +$370K | 0.86% | 30 |
|
|
2020
Q2 | $12.5M | Buy |
127,649
+34,196
| +37% | +$3.01M | 0.99% | 27 |
|
|
2020
Q1 | $7.12M | Buy |
93,453
+5,435
| +6% | +$463K | 0.67% | 42 |
|
|
2019
Q4 | $7.79M | Buy |
88,018
+1,749
| +2% | +$145K | 0.57% | 49 |
|
|
2019
Q3 | $6.53M | Buy |
86,269
+67,397
| +357% | +$4.62M | 0.51% | 53 |
|
|
2019
Q2 | $1.37M | Buy |
18,872
+2,432
| +15% | +$191K | 0.11% | 153 |
|
|
2019
Q1 | $1.32M | Sell |
16,440
-2,741
| -14% | -$224K | 0.11% | 157 |
|
|
2018
Q4 | $1.77M | Sell |
19,181
-1,883
| -9% | -$166K | 0.16% | 136 |
|
|
2018
Q3 | $1.99M | Buy |
21,064
+67
| +0.3% | +$6.35K | 0.16% | 137 |
|
|
2018
Q2 | $1.94M | Buy |
20,997
+11,184
| +114% | +$1.09M | 0.16% | 136 |
|
|
2018
Q1 | $927K | Sell |
9,813
-441
| -4% | -$48.4K | 0.09% | 161 |
|
|
2017
Q4 | $993K | Buy |
10,254
+3,441
| +51% | +$324K | 0.09% | 163 |
|
|
2017
Q3 | $607K | Sell |
6,813
-165
| -2% | -$12.6K | 0.06% | 189 |
|
|
2017
Q2 | $504K | Buy |
6,978
+3,088
| +79% | +$208K | 0.05% | 202 |
|
|
2017
Q1 | $254K | Sell |
3,890
-6,211
| -61% | -$390K | 0.03% | 293 |
|
|
2016
Q4 | $630K | Hold |
10,101
| – | – | 0.08% | 191 |
|
|
2016
Q3 | $630K | Buy |
10,101
+5,174
| +105% | +$335K | 0.08% | 188 |
|
|
2016
Q2 | $304K | Sell |
4,927
-3,225
| -40% | -$197K | 0.04% | 243 |
|
|
2016
Q1 | $484K | Buy |
8,152
+1,913
| +31% | +$107K | 0.05% | 213 |
|
|
2015
Q4 | $369K | Buy |
6,239
+1,562
| +33% | +$90K | 0.07% | 202 |
|
|
2015
Q3 | $254K | Buy |
4,677
+398
| +9% | +$25.9K | 0.04% | 248 |
|
|
2015
Q2 | $287K | Buy |
4,279
+136
| +3% | +$8.88K | 0.04% | 252 |
|
|
2015
Q1 | $242K | Buy |
4,143
+944
| +30% | +$57K | 0.04% | 284 |
|
|
2014
Q4 | $209K | Sell |
3,199
-266
| -8% | -$16.8K | 0.03% | 302 |
|
|
2014
Q3 | $199K | Sell |
3,465
-11,850
| -77% | -$658K | 0.03% | 304 |
|
|
2014
Q2 | $864K | Buy |
15,315
+1,384
| +10% | +$72.6K | 0.13% | 172 |
|
|
2014
Q1 | $716K | Sell |
13,931
-306
| -2% | -$15.5K | 0.1% | 179 |
|
|
2013
Q4 | $750K | Sell |
14,237
-55
| -0.4% | -$2.7K | 0.11% | 171 |
|
|
2013
Q3 | $639K | Buy |
14,292
+14,176
| +12,221% | +$628K | 0.1% | 176 |
|
|
2013
Q2 | $5K | Buy |
+116
| New | +$5.07K | ﹤0.01% | 661 |
|
Other funds holding ABBV
First Horizon Advisors's ABBV Position: Q2 2025 in Review
First Horizon Advisors increased its AbbVie (ABBV) stake by 4.7% in Q2 2025, buying an estimated $1.37M and bringing the position to 162,391 shares worth $30.1M. The position accounts for 0.78% of the portfolio, ranked #37.
First Horizon Advisors first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $34.4M in Q3 2024. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.
- First Horizon Advisors held 162,391 shares of AbbVie worth $30.1M as of Q2 2025.
- First Horizon Advisors bought 7,361 AbbVie shares in Q2 2025, an estimated $1.37M.
- AbbVie made up 0.78% of First Horizon Advisors's portfolio in Q2 2025, its #37 holding.
- First Horizon Advisors first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's AbbVie position peaked at $34.4M in Q3 2024.
- 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.